Symple Surgical Inc.

Symple Surgical Inc. is a medical device company that is revolutionizing therapeutic technologies through controlled microwave ablation. Their flagship product, DirectAblate GRIZZLY and the Microwave Ablation System, are designed to prioritize user-friendly operation and enhanced patient safety. The company, which was founded in 2013, operates within the Health Care and Manufacturing industries and is headquartered in the United States. The most recent investment, totaling $399.83K, was a grant investment from the National Cancer Institute on 01 February 2022. Symple Surgical's technologies are meticulously created to be user-friendly for operators, while simultaneously ensuring automated control, feedback, and most importantly, patient safety. The company operates privately and is equipped with engineering and product development offices in Sacramento, California and Flagstaff, Arizona. The team comprises seasoned medical device professionals, covering global expertise spanning from research and development to product commercialization. In an industry ripe for innovation, Symple Surgical Inc. stands out for its pioneering approach and commitment to advancing therapeutic technologies, particularly in the realm of controlled microwave ablation. With a strong foundation, strategic partnerships, and a clear focus on user-centric design and patient safety, Symple Surgical Inc. is poised to make a significant impact within the healthcare landscape.